{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P35869",
      "entity_text" : "AhR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:445154",
      "entity_text" : "resveratrol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Several pieces of evidence point to AhR as a potential new target in the management of IBD and suggest that the modulation of AhR signaling pathway via diet, smoking cessation, or the consumption of AhR antagonists such as resveratrol [XREF_BIBR] could be a viable new strategy for the prevention and treatment of IBD.",
  "reading_complete" : "2020-08-04T14:13:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:11:06Z",
  "trigger" : "antagonists",
  "evidence" : [ "AhR antagonists such as resveratrol" ],
  "pmc_id" : "3818893",
  "score" : 0
}